GARY DUBIN
Medical Practice in Norristown, PA
License number
Pennsylvania MD038154E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Norristown, PA 19406
Personal information
See more information about GARY DUBIN at radaris.comName
Address
Phone
3211 Shady Avenue Ext, Pittsburgh, PA 15217
1549 Tanglewood Dr, West Chester, PA 19380
1223 Bennington Ave, Pittsburgh, PA 15217
7230 Horrocks St, Philadelphia, PA 19149
2250 Tyson Ave, Philadelphia, PA 19149
Professional information
See more information about GARY DUBIN at trustoria.com
Hpv-16 And-18 L1 Vlp Vaccine
Hpv-16 And-18 L1 Vlp Vaccine
US Patent:
2006025, Nov 9, 2006
Filed:
Dec 18, 2003
Appl. No.:
10/540099
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Wettendorff - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Wettendorff - King of Prussia PA, US
International Classification:
A61K 39/12
US Classification:
424204100
Abstract:
The invention relates to use of HPV 16 and HPV 18 VLPs to provide cross protection against infection and/or disease by other HPV types.
Assay
Assay
US Patent:
2005003, Feb 17, 2005
Filed:
Aug 6, 2002
Appl. No.:
10/485838
Inventors:
Brigitte Colau - Rixensart, BE
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - King of Prussia PA, US
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - King of Prussia PA, US
International Classification:
C12Q001/68, C12P019/34
US Classification:
435006000, 435091200
Abstract:
A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
Assay
Assay
US Patent:
2007003, Feb 8, 2007
Filed:
Oct 12, 2006
Appl. No.:
11/581251
Inventors:
Brigitte Desiree Colau - Rixensart, BE
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - Delft, NL
Leen-Jan Van Doorn - Delft, NL
Gary Dubin - King of Prussia PA, US
Marie-Therese Martin - Rixensart, BE
Wim Quint - Delft, NL
Leen-Jan Van Doorn - Delft, NL
International Classification:
C12Q 1/68, C12P 19/34, C12Q 1/70
US Classification:
435005000, 435006000, 435091200
Abstract:
A process for identification of type-specific polynucleotide sequences in a sample, the process comprising the steps of (1) contacting polynucleotides from the sample, or derived from the sample, with a plurality of type-specific probes in the context of a solid support, and detection of any type-specific hybridisation; and (2) contacting polynucleotides in the sample, or derived from the sample, with type-specific primers for those types capable of being detected by the hybridisation step in step 1, but not so detected, in a type-specific amplification reaction.
Vaccine
Vaccine
US Patent:
2005028, Dec 29, 2005
Filed:
Apr 26, 2005
Appl. No.:
11/114301
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Cecile Wettendorff - Rixensart, BE
Bruce Innis - King of Prussia PA, US
Moncef Slaoui - King of Prussia PA, US
Martine Cecile Wettendorff - Rixensart, BE
International Classification:
A61K039/12
US Classification:
424186100
Abstract:
This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
Vaccine
Vaccine
US Patent:
7858098, Dec 28, 2010
Filed:
Dec 16, 2005
Appl. No.:
11/367601
Inventors:
Gary Dubin - King of Prussia PA, US
Bruce Innis - King of Prussia PA, US
Moncef Mohammed Slaoui - King of Prussia PA, US
Martine Anne Cecile Wettendorff - Rixensart, BE
Bruce Innis - King of Prussia PA, US
Moncef Mohammed Slaoui - King of Prussia PA, US
Martine Anne Cecile Wettendorff - Rixensart, BE
Assignee:
GlaxoSmithKline Biologicals, s.a. - Rixensart
International Classification:
A61K 39/12, A61K 39/295
US Classification:
4242041
Abstract:
This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.